Literature DB >> 20463753

Self-complementary AAV mediates gene targeting and enhances endonuclease delivery for double-strand break repair.

M L Hirsch1, L Green, M H Porteus, R J Samulski.   

Abstract

Adeno-associated virus (AAV) mediates gene targeting in humans by providing exogenous DNA for allelic replacement through homologous recombination. In comparison to other methods of DNA delivery or alternative DNA substrates, AAV gene targeting is reported to be very efficient, perhaps due to its single-stranded DNA genome, the inverted terminal repeats (ITRs), and/or the consequence of induced cellular signals on infection or uncoating. These viral attributes were investigated in the presence and absence of an I-Sce endonuclease-induced double-strand break (DSB) within a chromosomal defective reporter in human embryonic kidney cells. Gene correction was evaluated using self-complementary (sc) AAV, which forms a duplexed DNA molecule and results in earlier and robust transgene expression compared with conventional single-strand (ss) AAV genomes. An scAAV repair substrate was modestly enhanced for reporter correction showing no dependency on ssAAV genomes for this process. The AAV ITR sequences were also investigated in a plasmid repair context. No correction was noted in the absence of a DSB, however, a modest inhibitory effect correlated with the increasing presence of ITR sequences. Similarly, signaling cascades stimulated upon recombinant AAV transduction had no effect on plasmid-mediated DSB repair. Noteworthy, was the 20-fold additional enhancement in reporter correction using scAAV vectors, over ss versions, to deliver both the repair substrate and the endonuclease. In this case, homologous recombination repaired the defective reporter in 4% of cells without any selection. This report provides novel insights regarding the recombination substrates used by AAV vectors in promoting homologous recombination and points to the initial steps in vector optimization that could facilitate their use in gene correction of genetic disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463753      PMCID: PMC3152950          DOI: 10.1038/gt.2010.65

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  39 in total

1.  Stimulation of homologous recombination through targeted cleavage by chimeric nucleases.

Authors:  M Bibikova; D Carroll; D J Segal; J K Trautman; J Smith; Y G Kim; S Chandrasegaran
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Chimeric nucleases stimulate gene targeting in human cells.

Authors:  Matthew H Porteus; David Baltimore
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

4.  Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks.

Authors:  Matthew H Porteus; Toni Cathomen; Matthew D Weitzman; David Baltimore
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

5.  Introduction of single base substitutions at homologous chromosomal sequences by adeno-associated virus vectors.

Authors:  N Inoue; R Dong; R K Hirata; D W Russell
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

6.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro.

Authors:  B E Reubinoff; M F Pera; C Y Fong; A Trounson; A Bongso
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

7.  Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis.

Authors:  D M McCarty; P E Monahan; R J Samulski
Journal:  Gene Ther       Date:  2001-08       Impact factor: 5.250

8.  Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice.

Authors:  Hiroyuki Nakai; Eugenio Montini; Sally Fuess; Theresa A Storm; Leonard Meuse; Milton Finegold; Markus Grompe; Mark A Kay
Journal:  Mol Ther       Date:  2003-01       Impact factor: 11.454

9.  Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks.

Authors:  Daniel G Miller; Lisa M Petek; David W Russell
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

10.  Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose.

Authors:  Zhijian Wu; Junjiang Sun; Taiping Zhang; Chaoying Yin; Fang Yin; Terry Van Dyke; Richard J Samulski; Paul E Monahan
Journal:  Mol Ther       Date:  2007-12-04       Impact factor: 11.454

View more
  17 in total

Review 1.  Molecular therapy of primary hyperoxaluria.

Authors:  Cristina Martin-Higueras; Armando Torres; Eduardo Salido
Journal:  J Inherit Metab Dis       Date:  2017-04-19       Impact factor: 4.982

2.  Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors.

Authors:  Eva-Maria Händel; Katharina Gellhaus; Kafaitullah Khan; Christien Bednarski; Tatjana I Cornu; Felix Müller-Lerch; Robert M Kotin; Regine Heilbronn; Toni Cathomen
Journal:  Hum Gene Ther       Date:  2011-12-14       Impact factor: 5.695

3.  Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.

Authors:  Blythe D Sather; Guillermo S Romano Ibarra; Karen Sommer; Gabrielle Curinga; Malika Hale; Iram F Khan; Swati Singh; Yumei Song; Kamila Gwiazda; Jaya Sahni; Jordan Jarjour; Alexander Astrakhan; Thor A Wagner; Andrew M Scharenberg; David J Rawlings
Journal:  Sci Transl Med       Date:  2015-09-30       Impact factor: 17.956

Review 4.  Gene therapy approaches for prevention of retinal degeneration in Usher syndrome.

Authors:  D S Williams; A Chadha; R Hazim; D Gibbs
Journal:  Gene Ther       Date:  2017-01-05       Impact factor: 5.250

5.  Adeno-associated virus inverted terminal repeats stimulate gene editing.

Authors:  M L Hirsch
Journal:  Gene Ther       Date:  2014-12-11       Impact factor: 5.250

6.  Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs.

Authors:  B L Ellis; M L Hirsch; S N Porter; R J Samulski; M H Porteus
Journal:  Gene Ther       Date:  2012-01-19       Impact factor: 5.250

7.  CRISPR-READI: Efficient Generation of Knockin Mice by CRISPR RNP Electroporation and AAV Donor Infection.

Authors:  Sean Chen; Sabrina Sun; Dewi Moonen; Clancy Lee; Angus Yiu-Fai Lee; David V Schaffer; Lin He
Journal:  Cell Rep       Date:  2019-06-25       Impact factor: 9.423

8.  AAV-mediated gene editing via double-strand break repair.

Authors:  Matthew L Hirsch; R Jude Samulski
Journal:  Methods Mol Biol       Date:  2014

9.  The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting.

Authors:  Shamim H Rahman; Sylwia Bobis-Wozowicz; Debanjana Chatterjee; Katharina Gellhaus; Kaweh Pars; Regine Heilbronn; Roland Jacobs; Toni Cathomen
Journal:  Hum Gene Ther       Date:  2012-12-10       Impact factor: 5.695

10.  A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype.

Authors:  Brian L Ellis; Matthew L Hirsch; Jenny C Barker; Jon P Connelly; Robert J Steininger; Matthew H Porteus
Journal:  Virol J       Date:  2013-03-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.